Overview

The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The generic formulation of atorvastatin (Atorva®) 20mg was not inferior to the branded formulation of atorvastatin (Lipitor®) 20mg in this 8-week treatment of hyperlipidemic Korean patients. In PP analysis, the LDL cholesterol goal achievement rate was significantly higher in Atorva group. Both treatments were well tolerated.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Yuhan corp., Seoul, Korea
Treatments:
Atorvastatin
Atorvastatin Calcium